Nagasawa K, Tsukamoto H, Tada Y, Mayumi T, Satoh H, Onitsuka H, Kuwabara Y, Niho Y
First Department of Internal Medicine, Faculty of Medicine, Kyushu University, Fukuoka, Japan.
Br J Rheumatol. 1994 Apr;33(4):343-7. doi: 10.1093/rheumatology/33.4.343.
To find out when and how avascular necrosis of the femoral head (ANFH) develops in patients with SLE who are receiving corticosteroids, we carried out a 3-yr prospective study using imaging methods. Twenty-three patients with SLE who were free of hip pain and radiographically negative were enrolled in the study. Initially, abnormal findings characteristic of ANFH were detected in eight (35%) and six (26%) patients on MRI and radionuclide uptake bone scanning, respectively. During a 3-yr observation period abnormalities on MRI, bone scanning and radiography were found in four, five and four patients, respectively and three patients developed hip pain. Analyses of imaging changes demonstrated that only a small proportion of patients (2/8, 25%) who initially showed abnormal MRI progressed to be radiographically positive for ANFH over the 3 years. High doses of corticosteroids over the 3-yr period were to be responsible for the emergence of change in MRI abnormalities. It is also suggested that abnormal MRI findings tend to develop either within a relatively short interval after the start of corticosteroid treatment or are associated with the exacerbation of SLE.
为了明确正在接受皮质类固醇治疗的系统性红斑狼疮(SLE)患者股骨头缺血性坏死(ANFH)的发生时间和发展方式,我们采用影像学方法进行了一项为期3年的前瞻性研究。23例无髋部疼痛且X线检查阴性的SLE患者纳入本研究。最初,分别在8例(35%)和6例(26%)患者的MRI和放射性核素摄取骨扫描中检测到ANFH的特征性异常表现。在3年的观察期内,分别有4例、5例和4例患者在MRI、骨扫描和X线检查中发现异常,3例患者出现髋部疼痛。影像学变化分析表明,在最初MRI显示异常的患者中,只有一小部分(2/8,25%)在3年内进展为ANFH X线检查阳性。3年内高剂量皮质类固醇治疗是MRI异常改变出现的原因。还提示MRI异常表现往往在皮质类固醇治疗开始后的相对短时间内出现,或与SLE病情加重有关。